RecruitingNot ApplicableNCT07738874

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 3 (BabySTEPS3)


Sponsor

Duke University

Enrollment

175 participants

Start Date

Dec 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Retinopathy of prematurity (ROP) is a disorder of development of the retina and its vasculature that can impact vision in vulnerable preterm neonates for a lifetime. A major barrier to improving ROP outcomes is the lack of easy access and low stress means to obtain objective measures of ROP disease severity across the retina in these infants. The long-term goal of this program is to provide information which will improve preterm infant health and vision via objective bedside imaging and analysis that characterizes retina-wide ROP level of disease, its response to treatment and development, and to rapidly translate this for better early intervention and improved future vision care.


Eligibility

Min Age: 0 DaysMax Age: 9 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Ultra-widefield Optical Coherence Tomography (UWF-OCT) and a medical device called Wide-field ophthalmic imaging system for people with retinopathy of prematurity (rop). The study is currently recruiting participants at 2 locations. People eligible for this study include aged 0 Days to 9 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEUltra-widefield Optical Coherence Tomography (UWF-OCT)

Handheld retinal OCT imaging at the bedside or in clinic with an ultra-widefield handheld optical coherence tomography

DEVICEWide-field ophthalmic imaging system

Handheld wide-field ophthalmic fundus imaging at the bedside or in clinic


Locations(2)

Duke University Eye Center

Durham, North Carolina, United States

University of Pennsylvania, Center for Preventive Ophthalmology and Biostatistics

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07738874


Related Trials